dc.contributor.author | Gündoğan, G.İ. | |
dc.contributor.author | Kig, C. | |
dc.contributor.author | Karacan, M. | |
dc.contributor.author | Doğruman, H. | |
dc.date.accessioned | 2021-12-21T08:40:36Z | |
dc.date.available | 2021-12-21T08:40:36Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1304530X | |
dc.identifier.uri | https://doi.org/10.4274/tjps.galenos.2020.58827 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1102 | |
dc.description.abstract | Objectives: Dehydroepiandrosterone (DHEA) is an endogenous hormone that acts as a ligand for several cellular receptors. An age-dependent decline in circulating levels of DHEA is linked to changes in various physiological functions. In gynecological clini | |
dc.language.iso | English | |
dc.publisher | Turkish Pharmacists Association | |
dc.rights | All Open Access, Bronze, Green | |
dc.title | Investigation of physiological effects induced by dehydroepiandrosterone in human endothelial cells and ovarian cancer cell line [İnsan endotel hücreleri ve ovaryum kanseri hücre hattında dehidroepiandrosteronun neden olduğu fizyolojik etkilerin araştırıl | |
dc.type | Article | |
dc.relation.journal | Turkish Journal of Pharmaceutical Sciences | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 185 | |
dc.identifier.endpage | 191 | |
dc.identifier.volume | 18 | |
dc.identifier.doi | 10.4274/tjps.galenos.2020.58827 | |
dc.relation.issue | 2 | |
dc.relation.volume | 18 | |